News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
322,973 Results
Type
Article (18918)
Company Profile (37)
Press Release (304017)
Multimedia
Podcasts (16)
Webinars (3)
Section
Business (87930)
Career Advice (1073)
Deals (16336)
Drug Delivery (34)
Drug Development (46205)
Employer Resources (25)
FDA (7708)
Job Trends (6780)
News (157600)
Policy (12899)
Tag
Academia (785)
Accelerated approval (20)
Adcomms (10)
Allergies (68)
Alliances (16747)
ALS (85)
Alzheimer's disease (686)
Antibody-drug conjugate (ADC) (139)
Approvals (7986)
Artificial intelligence (137)
Autoimmune disease (61)
Automation (7)
Bankruptcy (139)
Best Places to Work (5435)
BIOSECURE Act (6)
Biosimilars (91)
Biotechnology (22)
Bladder cancer (113)
Brain cancer (29)
Breast cancer (376)
Cancer (2598)
Cardiovascular disease (220)
Career advice (925)
Career pathing (8)
CAR-T (103)
CDC (11)
Celiac Disease (1)
Cell therapy (332)
Cervical cancer (22)
Clinical research (40712)
Collaboration (499)
Compensation (473)
Complete response letters (20)
COVID-19 (1249)
CRISPR (30)
C-suite (180)
Cystic fibrosis (58)
Data (3846)
Denatured (2)
Depression (61)
Diabetes (261)
Diagnostics (2400)
Digital health (16)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (73)
Drug pricing (43)
Drug shortages (7)
Duchenne muscular dystrophy (117)
Earnings (55216)
Editorial (13)
Employer branding (5)
Employer resources (21)
Events (52830)
Executive appointments (220)
FDA (9383)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (470)
Gene editing (83)
Generative AI (11)
Gene therapy (274)
GLP-1 (465)
Government (1632)
Grass and pollen (4)
Guidances (345)
Healthcare (7477)
HIV (35)
Huntington's disease (21)
IgA nephropathy (47)
Immunology and inflammation (137)
Immuno-oncology (24)
Indications (46)
Infectious disease (1355)
Inflammatory bowel disease (90)
Inflation Reduction Act (1)
Influenza (37)
Intellectual property (97)
Interviews (249)
IPO (9121)
IRA (8)
Job creations (1601)
Job search strategy (680)
Kidney cancer (9)
Labor market (36)
Layoffs (198)
Leadership (5)
Legal (2552)
Liver cancer (36)
Longevity (4)
Lung cancer (363)
Lymphoma (248)
Machine learning (9)
Management (4)
Manufacturing (238)
MASH (105)
Medical device (5215)
Medtech (5227)
Mergers & acquisitions (7636)
Metabolic disorders (647)
Multiple sclerosis (97)
NASH (5)
Neurodegenerative disease (128)
Neuropsychiatric disorders (44)
Neuroscience (1287)
NextGen: Class of 2026 (2131)
Non-profit (1451)
Now hiring (13)
Obesity (283)
Opinion (74)
Ovarian cancer (104)
Pain (72)
Pancreatic cancer (130)
Parkinson's disease (135)
Partnered (10)
Patents (217)
Patient recruitment (221)
Peanut (29)
People (16176)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase I (12157)
Phase II (18616)
Phase III (13993)
Pipeline (2995)
Policy (55)
Postmarket research (1512)
Preclinical (4213)
Press Release (10)
Prostate cancer (104)
Psychedelics (26)
Radiopharmaceuticals (105)
Rare diseases (385)
Real estate (2017)
Recruiting (12)
Regulatory (10690)
Reports (25)
Research institute (757)
Resumes & cover letters (185)
Rett syndrome (22)
RNA editing (7)
RSV (33)
Schizophrenia (92)
Series A (63)
Series B (64)
Service/supplier (3)
Sickle cell disease (67)
Special edition (11)
Spinal muscular atrophy (98)
Sponsored (14)
Startups (1131)
State (1)
Stomach cancer (6)
Supply chain (27)
Tariffs (22)
The Weekly (14)
Vaccines (444)
Venture capital (30)
Weight loss (172)
Women's health (36)
Worklife (6)
Date
Last 7 days (388)
Last 30 days (1018)
Last 365 days (15397)
2026 (406)
2025 (15278)
2024 (16815)
2023 (17989)
2022 (25401)
2021 (26221)
2020 (23890)
2019 (18329)
2018 (12984)
2017 (12135)
2016 (10755)
2015 (13609)
2014 (9632)
2013 (6925)
2012 (7688)
2011 (22245)
2010 (39350)
Location
Africa (285)
Alabama (26)
Alaska (1)
Arizona (106)
Arkansas (2)
Asia (19091)
Australia (2978)
California (5269)
Canada (1472)
China (535)
Colorado (185)
Connecticut (239)
Delaware (180)
Europe (45513)
Florida (662)
Georgia (183)
Idaho (20)
Illinois (370)
India (31)
Indiana (268)
Iowa (6)
Japan (256)
Kansas (49)
Kentucky (13)
Louisiana (13)
Maine (38)
Maryland (627)
Massachusetts (3819)
Michigan (106)
Minnesota (273)
Mississippi (2)
Missouri (49)
Montana (9)
Nebraska (3)
Nevada (51)
New Hampshire (42)
New Jersey (1658)
New Mexico (2)
New York (1523)
North Carolina (710)
Northern California (2645)
Ohio (122)
Oklahoma (2)
Oregon (8)
Pennsylvania (1052)
Puerto Rico (6)
Rhode Island (9)
South America (466)
South Carolina (17)
Southern California (2073)
Tennessee (39)
Texas (727)
United States (18533)
Utah (123)
Virginia (76)
Washington D.C. (21)
Washington State (369)
West Virginia (2)
Wisconsin (29)
322,973 Results for "12".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
January 8, 2026
·
1 min read
·
Chantal Dresner
Press Releases
FDA Grants Fast Track Designation to Cothera Bioscience’s Zotiraciclib for Treatment of Recurrent High-Grade Glioma with IDH1/2 Mutations
Breakthrough oral CDK9 inhibitor advances care for patients with recurrent high-grade gliomas harboring IDH1/2 mutations
November 26, 2025
·
1 min read
Press Releases
Ipsen – Half year statement – 2025 12 31
January 7, 2026
·
5 min read
Press Releases
Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
December 30, 2025
·
10 min read
Press Releases
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
January 7, 2026
·
1 min read
Press Releases
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
January 2, 2026
·
6 min read
Press Releases
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
January 5, 2026
·
2 min read
Press Releases
Prothena Announces Board of Directors Update - December 12, 2025
December 15, 2025
·
2 min read
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
The deals will help Lilly diversify its portfolio that is heavily weighted on the obesity juggernaut tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss.
January 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
4DMT Announces New Employment Inducement Grants - December 12, 2025
December 15, 2025
·
2 min read
1 of 32,298
Next
